Literature DB >> 22079429

Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Shyamala Ganesan1, Andrea N Faris, Adam T Comstock, Joanne Sonstein, Jeffrey L Curtis, Uma S Sajjan.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) is an important bacterial pathogen associated with lower respiratory tract colonization and with acute exacerbations and disease progression in chronic obstructive pulmonary disease (COPD). Why the immune system fails to eliminate NTHi and the exact contribution of the organism to COPD progression are not well understood, in part because we lack an animal model that mimics all aspects of COPD. For this study, we used an established murine model that exhibits typical features of COPD. Elastase/LPS-exposed mice infected with NTHi showed persistence of bacteria up to 5 days after infection, whereas mice exposed to elastase, LPS, or PBS cleared all bacteria by 3 days. Elastase/LPS-exposed mice also showed sustained lung neutrophilic inflammation, goblet cell metaplasia, airway hyperresponsiveness, and progression of emphysema at 15 days after infection. Alveolar macrophages isolated from elastase/LPS-exposed mice showed impaired bacterial phagocytosis, reduced expression of MARCO and of mannose receptor, and absent expression of scavenger receptor-A (SR-A). Neutralization of SR-A significantly decreased phagocytosis of NTHi by normal alveolar macrophages. Our results suggest that elastase/LPS-exposed mice show impaired bacterial clearance and sustained lung inflammation. Lack of SR-A expression may, in part, be responsible for impaired phagocytosis of bacteria by alveolar macrophages of elastase/LPS-exposed mice. These data validate the suitability of elastase/LPS model for investigating NTHi pathogenesis and progression of disease in COPD.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079429      PMCID: PMC3338352          DOI: 10.1016/j.ajpath.2011.09.029

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Role of viruses in exacerbations of chronic obstructive pulmonary disease.

Authors:  Jadwiga A Wedzicha
Journal:  Proc Am Thorac Soc       Date:  2004

2.  Elevated MMP-12 protein levels in induced sputum from patients with COPD.

Authors:  I K Demedts; A Morel-Montero; S Lebecque; Y Pacheco; D Cataldo; G F Joos; R A Pauwels; G G Brusselle
Journal:  Thorax       Date:  2005-11-24       Impact factor: 9.139

3.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

Authors:  R D Hautamaki; D K Kobayashi; R M Senior; S D Shapiro
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 4.  Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease.

Authors:  Nader Eldika; Sanjay Sethi
Journal:  Curr Opin Pulm Med       Date:  2006-03       Impact factor: 3.155

5.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.

Authors:  Ana Maria B Menezes; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Maria Montes de Oca; Carlos Talamo; Pedro C Hallal; Cesar G Victora
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

6.  Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection.

Authors:  Anna G Drannik; Mahmoud A Pouladi; Clinton S Robbins; Susanna I Goncharova; Sussan Kianpour; Martin R Stämpfli
Journal:  Am J Respir Crit Care Med       Date:  2004-08-18       Impact factor: 21.405

7.  A 15-year follow-up study of ventilatory function in adults with asthma.

Authors:  P Lange; J Parner; J Vestbo; P Schnohr; G Jensen
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

8.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

Authors:  J Vestbo; E Prescott; P Lange
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

9.  Elastase- and LPS-exposed mice display altered responses to rhinovirus infection.

Authors:  Umadevi Sajjan; Shyamala Ganesan; Adam T Comstock; Jee Shim; Qiong Wang; Deepti R Nagarkar; Ying Zhao; Adam M Goldsmith; Joanne Sonstein; Marisa J Linn; Jeffrey L Curtis; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-11       Impact factor: 5.464

10.  The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock.

Authors:  R Haworth; N Platt; S Keshav; D Hughes; E Darley; H Suzuki; Y Kurihara; T Kodama; S Gordon
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  22 in total

1.  Why do we need a nonhuman primate model of smoking-induced COPD?

Authors:  Jeffrey L Curtis; Christine M Freeman
Journal:  Am J Pathol       Date:  2015-01-07       Impact factor: 4.307

Review 2.  It's a cell-eat-cell world: autophagy and phagocytosis.

Authors:  Elizabeth A Oczypok; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2013-01-29       Impact factor: 4.307

3.  World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Mingzhu Fang; Helmut Zarbl; Christopher Massa; Andrew J Gow; Jessica A Cervelli; Howard Kipen; Robert J Laumbach; Paul J Lioy; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2016-12-13       Impact factor: 3.362

4.  Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.

Authors:  Jennifer L Booth; Todd M Umstead; Sanmei Hu; Kevin F Dybvig; Timothy K Cooper; Ronald P Wilson; Zissis C Chroneos
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

5.  Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD.

Authors:  Matthew R Lammi; Mohamed A Ghonim; Kusma Pyakurel; Amarjit S Naura; Salome V Ibba; Christian J Davis; Samuel C Okpechi; Kyle I Happel; Bennett P deBoisblanc; Judd Shellito; A Hamid Boulares
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-05       Impact factor: 5.464

6.  Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation.

Authors:  K Venuprasad; Balamayooran Theivanthiran; Brandi Cantarel
Journal:  J Vis Exp       Date:  2016-03-02       Impact factor: 1.355

7.  MyD88 controls airway epithelial Muc5ac expression during TLR activation conditions from agricultural organic dust exposure.

Authors:  John D Dickinson; Jenea M Sweeter; Elizabeth B Staab; Amy J Nelson; Kristina L Bailey; Kristi J Warren; Ana Maria Jaramillo; Burton F Dickey; Jill A Poole
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

8.  Changes in Expression of the Membrane Receptors CD14, MHC-II, SR-A, and TLR4 in Tissue-Specific Monocytes/Macrophages Following Porphyromonas gingivalis-LPS Stimulation.

Authors:  Chunfang Wu; Chongwu Liu; Kai Luo; Yanfen Li; Jun Jiang; Fuhua Yan
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 9.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

10.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.